{
    "Trade/Device Name(s)": [
        "Nova Max One Blood Glucose Monitoring System",
        "Nova Max One Glucose Test Strips",
        "Nova Max Control Solutions"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K112638",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070255",
        "K051839",
        "K092638"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "January 30, 2012",
    "Summary Letter Received Date": "February 1, 2012",
    "Submission Date": "12/19/2011",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Nova Max One Blood Glucose Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection (coulometric sensor)",
        "Glucose dehydrogenase-FAD chemistry"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Strips",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Nova Max One Blood Glucose Monitoring System for quantitative glucose measurement in fresh capillary whole blood",
    "Indications for Use Summary": "For self-testing by individuals with diabetes mellitus to quantitatively measure glucose in fresh capillary whole blood from fingertip or forearm; intended for single-patient home use and not for diagnosis, screening, neonatal use, or multi-patient use.",
    "fda_folder": "Clinical Chemistry"
}